Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: Correlation with common genetic variants and disease activity

Arthritis Research and Therapy

Volumn 15, Issue 2, 2013, Pages

  Recarte Pelz, Pedro ^a   Tàssies, Dolors ^b   Espinosa, Gerard ^b   Hurtado, Begoña ^a   Sala, Núria ^c   Cervera, Ricard ^b   Reverter, Joan C ^b   de Frutos, Pablo G ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AXL PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; MERTK PROTEIN; PROTEIN S; PROTEIN TYROSINE KINASE; TYRO3 PROTEIN; UNCLASSIFIED DRUG; VITAMIN K GROUP; GROWTH ARREST-SPECIFIC PROTEIN 6; PEPTIDE FRAGMENT; PROTEIN S (159-245), HUMAN; SIGNAL PEPTIDE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN S; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; VITAMIN K;

EID: 84874792957     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4199     Document Type: Article

References (49)

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011, 365:2110-2121. 10.1056/NEJMra1100359, 22129255.
2. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004, 14:277-287. 10.1016/S1097-2765(04)00237-0, 15125832.
3. Ravichandran KS. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 2011, 35:445-455. 10.1016/j.immuni.2011.09.004, 3241945, 22035837.
4. Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008, 17:371-375. 10.1177/0961203308089990, 18490410.
5. Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J Immunol 2007, 178:5635-5642.
6. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, Earp HS, Matsushima G, Reap EA. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002, 196:135-140. 10.1084/jem.20012094, 2194017, 12093878.
7. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001, 411:207-211. 10.1038/35075603, 11346799.
8. Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001, 293:306-311. 10.1126/science.1061663, 11452127.
9. Bellido-Martin L, de Frutos PG. Vitamin K-dependent actions of Gas6. Vitam Horm 2008, 78:185-209.
10. Evenas P, Dahlback B, Garcia de Frutos P. The first laminin G-type domain in the SHBG-like region of protein S contains residues essential for activation of the receptor tyrosine kinase sky. Biol Chem 2000, 381:199-209.
11. Sasaki T, Knyazev PG, Clout NJ, Cheburkin Y, Gohring W, Ullrich A, Timpl R, Hohenester E. Structural basis for Gas6-Axl signalling. EMBO J 2006, 25:80-87. 10.1038/sj.emboj.7600912, 1356355, 16362042.
12. Balogh I, Hafizi S, Stenhoff J, Hansson K, Dahlback B. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 2005, 25:1280-1286. 10.1161/01.ATV.0000163845.07146.48, 15790929.
13. Hackeng TM, Rosing J. Protein S as cofactor for TFPI. Arterioscler Thromb Vasc Biol 2009, 29:2015-2020. 10.1161/ATVBAHA.108.177436, 19661488.
14. Nyberg P, He X, Hardig Y, Dahlback B, Garcia de Frutos P. Stimulation of Sky tyrosine phosphorylation by bovine protein S--domains involved in the receptor-ligand interaction. Eur J Biochem 1997, 246:147-154. 10.1111/j.1432-1033.1997.t01-2-00147.x, 9210477.
15. Garcia de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost 2007, 98:543-556.
16. Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2007, 109:1026-1033. 1785151, 17047157.
17. Png KJ, Halberg N, Yoshida M, Tavazoie SF. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 2011, 481:190-194. 10.1038/nature10661, 22170610.
18. Suh CH, Hilliard B, Li S, Merrill JT, Cohen PL. TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther 2010, 12:R146. 10.1186/ar3088, 2945040, 20637106.
19. Ekman C, Jonsen A, Sturfelt G, Bengtsson AA, Dahlback B. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 50:1064-1069.
20. Wu J, Ekman C, Jonsen A, Sturfelt G, Bengtsson AA, Gottsater A, Lindblad B, Lindqvist E, Saxne T, Dahlback B. Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis. Arthritis Res Ther 2011, 13:R62. 10.1186/ar3316, 3132057, 21496228.
21. Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 2004, 104:143-148. 10.1182/blood-2003-11-4085, 15026314.
22. Ekman C, Jonsen A, Sturfelt G, Bengtsson AA, Dahlback B. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2011, 50:1064-1069.
23. Hurtado B, Abasolo N, Munoz X, Garcia N, Benavente Y, Rubio F, Garcia de Frutos P, Krupinski J, Sala N. Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis. Thromb Haemost 2010, 104:592-598. 10.1160/TH09-11-0787, 20664904.
24. Munoz X, Obach V, Hurtado B, de Frutos PG, Chamorro A, Sala N. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost 2007, 98:406-412.
25. Munoz X, Sumoy L, Ramirez-Lorca R, Villar J, de Frutos PG, Sala N. Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke. Hum Mutat 2004, 23:506-512. 10.1002/humu.20025, 15108283.
26. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
27. American Rheumatism Association Glossary Committee Dictionary of the rheumatic diseases signs and symptoms 1982, 1:1-80. Bayport, New York: Contact Associates International, 1, American Rheumatism Association Glossary Committee.
28. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640. 10.1002/art.1780350606, 1599520.
29. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived O, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:809-813. 10.1002/art.1780400506, 9153540.
30. Alciato F, Sainaghi PP, Castello L, Bergamasco L, Carnieletto S, Avanzi GC. Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma. J Immunoassay Immunochem 2008, 29:167-180. 10.1080/15321810801888480, 18360812.
31. Zoller B, Garcia de Frutos P, Dahlback B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995, 85:3524-3531.
32. Kim HA, Nam JY, Jeon JY, An JM, Jung JY, Bae CB, Suh CH. Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. J Clin Immunol 2013, 33:143-150. 10.1007/s10875-012-9765-1, 22914895.
33. Lee IJ, Hilliard B, Swami A, Madara JC, Rao S, Patel T, Gaughan JP, Lee J, Gadegbeku CA, Choi ET, Cohen PL. Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant 2012, 27:4166-4172. 10.1093/ndt/gfs337, 22907951.
34. Lee CH, Chu NF, Shieh YS, Hung YJ. The growth arrest-specific 6 (Gas6) gene polymorphism c.834+7G > A is associated with type 2 diabetes. Diabetes Res Clin Pract 2011, 95:201-206.
35. Jiang HY, Lee KH, Schneider C, O WS, Tang PL, Chow PH. The growth arrest specific gene (gas6) protein is expressed in abnormal embryos sired by male golden hamsters with accessory sex glands removed. Anat Embryol (Berl) 2001, 203:343-355.
36. Cheong HS, Lee SO, Choi CB, Sung YK, Shin HD, Bae SC. MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients. Rheumatology (Oxford) 2007, 46:209-214.
37. Wu CS, Hu CY, Chan CJ, Chang SK, Hsu PN. Genetic polymorphism of the growth arrest-specific 6 gene is associated with cutaneous vasculitis in Taiwanese patients with systemic lupus erythematosus. Clin Rheumatol 2012, 31:1443-1448. 10.1007/s10067-012-2027-z, 22763415.
38. Ekman C, Stenhoff J, Dahlback B. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 2010, (8):838-844.
39. Mishra A, Wang J, Shiozawa Y, McGee S, Kim J, Jung Y, Joseph J, Berry JE, Havens A, Pienta KJ, Taichman RS. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. Mol Cancer Res 2012, 10:703-712. 10.1158/1541-7786.MCR-11-0569, 22516347.
40. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol 2008, 8:327-336. 10.1038/nri2303, 2856445, 18421305.
41. Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cdelta, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem 2011, 286:33335-33344. 10.1074/jbc.M111.263020, 3190938, 21828049.
42. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, Voll RE, Winkler T, Kuhn A, Kalden J, Kern P, Herrmann M. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 2007, 28:114-121. 10.1016/j.jaut.2007.02.005, 17368845.
43. Shao WH, Cohen PL. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther 2011, 13:202. 10.1186/ar3535, 3157636, 21371352.
44. Prasad D, Rothlin CV, Burrola P, Burstyn-Cohen T, Lu Q, Garcia de Frutos P, Lemke G. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci 2006, 33:96-108. 10.1016/j.mcn.2006.06.011, 16901715.
45. Uehara H, Shacter E. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic cells. J Immunol 2008, 180:2522-2530.
46. McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, Haslett C, Dransfield I. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol 2009, 183:2167-2175. 10.4049/jimmunol.0803503, 19597001.
47. Shao WH, Zhen Y, Eisenberg RA, Cohen PL. The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin Immunol 2009, 133:138-144. 10.1016/j.clim.2009.06.002, 2746995, 19631584.
48. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003, 4:87-91.
49. Silverman GJ. Rethinking the red wolf disease: does Protein S suppress systemic lupus erythematosus clinical activity?. Arthritis Res Ther 2010, 12:144. 10.1186/ar3162, 2991027, 21067626.